Enterprises of the Rostec State Corporation are actively developing the medical field, introducing high-tech solutions for diagnostics, treatment, and rehabilitation. Among the leaders are Rosel, Natsimbio, the Radioelectronic Technologies concern, CITO, Cardioelectronica, VanSel, and Tyazhpromexport.
One of the key achievements was the creation of the first Russian vaccine for adults against diphtheria, tetanus, and pertussis. Clinical studies have confirmed its high safety profile and effectiveness.
Rostec has also launched mass production of the domestic OneCell Scan 3.0 scanner, which allows for the fastest and most accurate diagnosis of oncological diseases using microscopic preparations.
A modern tuberculosis dispensary has been built in Khabarovsk, ready to receive its first patients. In addition, seven High-Tech Prosthetics Centers have already been opened in various regions of Russia. By 2028, it is planned to create 25 such institutions with a full cycle of prosthesis production and comprehensive rehabilitation of veterans of the Special Military Operation.
In the field of emergency care, Rostec has launched mass production of "Cardio Robots" that automatically regulate pressure and compression depth and can operate for up to 45 minutes without interruption. The new mobile ventilator "Mobivent ARM" is compact and suitable for medical transport and field hospitals.
The company has also launched the first domestic MRI-compatible pacemaker, Apollo MRI, which allows patients with severe arrhythmia to undergo MRI examinations without restrictions.
